NLM Logo

EVAP regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
EVAP regimen
Unique ID
C079611
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C079611
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Cytarabine
Etoposide
Vinblastine
Frequency
1
Note
chemotherapy regimen consisting of the above compounds; used in a pilot study designed to reduce delayed toxicity in the treatment of Hodgkin's disease in newly diagnosed children
Source
Br J Cancer 1993 Jan;67(1):159-62
Date of Entry
1993/03/09
Revision Date
2000/11/30
EVAP regimen Preferred
page delivered in 0.004s